<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191127045518N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-09-16</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Nano hydroxyapatite containing tooth paste on tooth discoloration during orthodontic treatment</public_title>
      <acronym></acronym>
      <scientific_title>The effect of Nano hydroxyapatite containing tooth paste on tooth discoloration during the first six months of fixed orthodontic treatment - A triple-blind randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-08-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>36</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49476</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization will be carried out using a computer-generated random number sequence to produce random samples. Each consecutive patient labeled by random number go through block randomization with a block length 18, Blinding description: The trial will be triple-blinded. Both the participants and clinician will be masked to group allocation and they will not be aware of the type of toothpaste. The laboratory technician taking the photographs will be masked to intervention. Furthermore, the individual analyzing the data will be unaware of the study protocol.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Tooth discoloration, Nanohydroxyapatite, Fixed Orthodontic treatment.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The teeth will be etched at the bracket base area with 37% phosphoric acid for 15 seconds, rinsed, and dried.  Transbond XT Adhesive Primer and Transbond XT Adhesive Resin  will be used for bonding metal brackets. Bonding procedures will be performed according to the manufacturer’s instructions. Stainless steel brackets will be placed and firmly pressed onto the enamel surfaces and excess adhesive will be removed from the bracket base periphery. If a slight bit of excess adhesive is present after setting (especially along the gingival margin), it will be removed with burs.patients in the experimental group will be brush at least 3 times a day with Nano hydroxyapatite toothpaste. Intervention 2: Control group: The teeth will be etched at the bracket base area with 37% phosphoric acid for 15 seconds, rinsed, and dried.  Transbond XT Adhesive Primer and Transbond XT Adhesive Resin  will be used for bonding metal brackets. Bonding procedures will be performed according to the manufacturer’s instructions. Stainless steel brackets will be placed and firmly pressed onto the enamel surfaces and excess adhesive will be removed from the bracket base periphery. If a slight bit of excess adhesive is present after setting (especially along the gingival margin), it will be removed with burs. patients in the control group will be brush at least 3 times a day with fluoride toothpaste.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All patient data can be tracked through the journal site

When:
The data will be provided to the journal and the exact time of availability of the information will be announced by the journal.

To whom:
Eligibility for access to information is determined by the relevant journal rules.

Conditions:
Eligibility for access to information is determined by the relevant journal rules.

Where to obtain:
All patient data can be tracked through the journal site. Therefore, by searching for articles on reputable sites, it will be possible to follow and access information

How to obtain:
All patient data can be tracked through the journal site. Therefore, by searching for articles on reputable sites, it will be possible to follow and access information

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ahmadreza Sardarian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz Dental School, Qasrdasht, Shiraz,</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7195615878</zip>
        <telephone>+98 917 718 8859</telephone>
        <email>sardarian@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ahmadreza Sardarian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz Dental School, Qasrdasht, Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7195615878</zip>
        <telephone>+98 917 718 8859</telephone>
        <email>sardarian@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>need for comprehensive orthodontic treatment by fixed appliances at least in the upper arch
permanent dentition
no plaque accumulation or gingival inflammation before bracket bonding
good general health</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>smoking habit
tooth anomalies
active dental caries</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The teeth will be etched at the bracket base area with 37% phosphoric acid for 15 seconds, rinsed, and dried.  Transbond XT Adhesive Primer and Transbond XT Adhesive Resin  will be used for bonding metal brackets. Bonding procedures will be performed according to the manufacturer’s instructions. Stainless steel brackets will be placed and firmly pressed onto the enamel surfaces and excess adhesive will be removed from the bracket base periphery. If a slight bit of excess adhesive is present after setting (especially along the gingival margin), it will be removed with burs.patients in the experimental group will be brush at least 3 times a day with Nano hydroxyapatite toothpaste.</i_keyword>
      <i_keyword>Control group: The teeth will be etched at the bracket base area with 37% phosphoric acid for 15 seconds, rinsed, and dried.  Transbond XT Adhesive Primer and Transbond XT Adhesive Resin  will be used for bonding metal brackets. Bonding procedures will be performed according to the manufacturer’s instructions. Stainless steel brackets will be placed and firmly pressed onto the enamel surfaces and excess adhesive will be removed from the bracket base periphery. If a slight bit of excess adhesive is present after setting (especially along the gingival margin), it will be removed with burs. patients in the control group will be brush at least 3 times a day with fluoride toothpaste.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Percentage of patients who have a color measurement criterion (ΔΕ) of more than one unit. Timepoint: The tooth color will be recorded 3 times during the first 6 months of fixed orthodontic treatment. At the start of the study and 3, 6 months during the treatment. Method of measurement: Digital photographic assessment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-29</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Orthodontics Research Center, Department of Orthodontics, Shiraz University of Medical Science, Shiraz, Iran. Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
